Predict your next investment

Asset/Investment Management

See what CB Insights has to offer

Investments

3

About Jiangyu Capital

Jiangyu Capital (疆域资本) is an asset & investment management firm.

Jiangyu Capital Headquarter Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Jiangyu Capital Investments

3 Investments

Jiangyu Capital has made 3 investments. Their latest investment was in Youlai Doctor as part of their Series A on July 7, 2018.

CBI Logo

Jiangyu Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/10/2018

Series A

Youlai Doctor

Yes

2

11/9/2017

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

10/12/2015

Seed VC

Subscribe to see more

Subscribe to see more

10

Date

7/10/2018

11/9/2017

10/12/2015

Round

Series A

Seed VC

Seed VC

Company

Youlai Doctor

Subscribe to see more

Subscribe to see more

Amount

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

10

10

Jiangyu Capital Team

2 Team Members

Jiangyu Capital has 2 team members, including current Founder, Fan Ni.

Name

Work History

Title

Status

Fan Ni

Founder

Current

Wenting Zhao

Founder

Current

Name

Fan Ni

Wenting Zhao

Work History

Title

Founder

Founder

Status

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.